(MCI) Barings Corporate Investors - Overview
Stock: Debt, High-Yield, Fixed-Income
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.82% |
| Yield on Cost 5y | 17.58% |
| Yield CAGR 5y | 13.62% |
| Payout Consistency | 93.6% |
| Payout Ratio | 2.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | -6.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -0.69 |
| Character TTM | |
|---|---|
| Beta | 0.079 |
| Beta Downside | 0.253 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.28% |
| CAGR/Max DD | 0.91 |
Description: MCI Barings Corporate Investors January 06, 2026
Babson Capital Corporate Investors Trust (NYSE:MCI) is a closed-ended mutual fund managed by Barings LLC that focuses on U.S. fixed-income markets, primarily holding privately placed, below-investment-grade, long-term corporate debt while maintaining secondary exposure to investment-grade bonds, other marketable debt, and common equities.
Established in 1971 and domiciled in the United States, the fund seeks diversification across multiple corporate sectors to mitigate issuer-specific risk, positioning itself within the high-yield segment of the credit market.
Recent fund metrics (as of the latest public filing) show a weighted-average coupon of roughly **7.5%**, a portfolio duration of about **5.5 years**, and net assets near **$1.2 billion**; the fund’s performance is closely tied to the high-yield spread, which has averaged **3.8%** over the past 12 months.
Key economic drivers include Federal Reserve interest-rate policy, the shape of the yield curve, and overall corporate issuance trends-particularly the supply of private placements, which can be constrained in a tightening credit environment.
For a deeper, data-driven assessment of MCI’s risk-adjusted performance, you may find ValueRay’s analytics platform useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 32.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -5.82 > 1.0 |
| NWC/Revenue: 40.57% < 20% (prev 50.34%; Δ -9.77% < -1%) |
| CFO/TA 0.03 > 3% & CFO 12.7m > Net Income 32.0m |
| Net Debt (36.6m) to EBITDA (36.3m): 1.01 < 3 |
| Current Ratio: 52.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.5m) vs 12m ago 0.68% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 10.49% > 50% (prev 10.87%; Δ -0.39% > 0%) |
| Interest Coverage Ratio: 43.24 > 6 (EBITDA TTM 36.3m / Interest Expense TTM 816.0k) |
Altman Z'' 2.75
| A: 0.04 (Total Current Assets 17.0m - Total Current Liabilities 321.0k) / Total Assets 400.5m |
| B: 0.12 (Retained Earnings 49.8m / Total Assets 400.5m) |
| C: 0.09 (EBIT TTM 35.3m / Avg Total Assets 391.5m) |
| D: 1.39 (Book Value of Equity 70.3m / Total Liabilities 50.5m) |
| Altman-Z'' Score: 2.75 = A |
What is the price of MCI shares?
Over the past week, the price has changed by -1.01%, over one month by +10.28%, over three months by +4.16% and over the past year by +4.61%.
Is MCI a buy, sell or hold?
What are the forecasts/targets for the MCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.7 | 25.2% |
MCI Fundamental Data Overview February 03, 2026
P/S = 10.3213
P/B = 1.2077
Revenue TTM = 41.1m USD
EBIT TTM = 35.3m USD
EBITDA TTM = 36.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 48.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 36.6m USD (from netDebt column, last quarter)
Enterprise Value = 460.4m USD (423.8m + Debt 48.4m - CCE 11.8m)
Interest Coverage Ratio = 43.24 (Ebit TTM 35.3m / Interest Expense TTM 816.0k)
EV/FCF = 36.18x (Enterprise Value 460.4m / FCF TTM 12.7m)
FCF Yield = 2.76% (FCF TTM 12.7m / Enterprise Value 460.4m)
FCF Margin = 30.99% (FCF TTM 12.7m / Revenue TTM 41.1m)
Net Margin = 77.86% (Net Income TTM 32.0m / Revenue TTM 41.1m)
Gross Margin = unknown ((Revenue TTM 41.1m - Cost of Revenue TTM 1.78m) / Revenue TTM)
Tobins Q-Ratio = 1.15 (Enterprise Value 460.4m / Total Assets 400.5m)
Interest Expense / Debt = 0.84% (Interest Expense 408.0k / Debt 48.4m)
Taxrate = 0.07% (4336 / 6.65m)
NOPAT = 35.3m (EBIT 35.3m * (1 - 0.07%))
Current Ratio = 52.90 (Total Current Assets 17.0m / Total Current Liabilities 321.0k)
Debt / Equity = 0.14 (Debt 48.4m / totalStockholderEquity, last quarter 350.0m)
Debt / EBITDA = 1.01 (Net Debt 36.6m / EBITDA 36.3m)
Debt / FCF = 2.87 (Net Debt 36.6m / FCF TTM 12.7m)
Total Stockholder Equity = 346.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.17% (Net Income 32.0m / Total Assets 400.5m)
RoE = 9.22% (Net Income TTM 32.0m / Total Stockholder Equity 346.8m)
RoCE = 8.82% (EBIT 35.3m / Capital Employed (Total Assets 400.5m - Current Liab 321.0k))
RoIC = 8.95% (NOPAT 35.3m / Invested Capital 393.9m)
WACC = 5.65% (E(423.8m)/V(472.1m) * Re(6.20%) + D(48.4m)/V(472.1m) * Rd(0.84%) * (1-Tc(0.00)))
Discount Rate = 6.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.52%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈21.4m ; Y1≈26.4m ; Y5≈45.0m
Fair Price DCF = 62.17 (EV 1.31b - Net Debt 36.6m = Equity 1.27b / Shares 20.5m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 25.30 | EPS CAGR: 0.37% | SUE: 3.34 | # QB: 1
Revenue Correlation: 73.95 | Revenue CAGR: 13.13% | SUE: N/A | # QB: 0